Is the FDA Killing Innovation? Fortune, September 2, 2011

/, Media Reports/Is the FDA Killing Innovation? Fortune, September 2, 2011

Is the FDA Killing Innovation? Fortune, September 2, 2011

CNN reports on MelaFind, a handheld medical device that helps doctors spot melanoma using a noninvasive computer imaging.  But it is still not approved by the Food and Drug Administration, and may not be.  The agency refused to take the next step to approval in 2009, even though the machine was on the fast-track. Uncertainty strangles innovation says one observer.

The balancing act of protecting public health versus the industry’s push to get new products to market was not helped by the Vioxx/Merck, GSK/Avandia scandals. Read more here.

 

By | 2011-09-03T03:38:17+00:00 September 3rd, 2011|FDA News, Media Reports|0 Comments

About the Author:

I’m National News Editor, Jane Akre and I began Mesh Medical Device News Desk aka Mesh News Desk (MND) in the summer of 2011 just after the Food and Drug Administration issued an explicit warning to the public that complications associated with surgical mesh used for prolapse repair (POP) and incontinence (SUI) are NOT rare! That was the starting point for the litigation you see today and thousands of lawsuits have been filed by women whose lives have been altered, some permanently, by the use of this petroleum-based product.

Leave A Comment